MD Anderson Cancer Center/University of Texas MD Anderson — Houston, Texas

MD Anderson Cancer Center/University of Texas MD Anderson is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center/University of Texas MD Anderson has participated in 2 clinical trials.

Therapeutic areas: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer, Myelodysplastic Syndromes.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center/University of Texas MD Anderson?

MD Anderson Cancer Center/University of Texas MD Anderson has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center/University of Texas MD Anderson conducted?

MD Anderson Cancer Center/University of Texas MD Anderson has 2 clinical trials on record. Their work covers Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer, Myelodysplastic Syndromes.

Is MD Anderson Cancer Center/University of Texas MD Anderson accredited by Crixeo Health?

MD Anderson Cancer Center/University of Texas MD Anderson has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center/University of Texas MD Anderson?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.